Right-sided cardiac echocardiographic parameters show no major change during 3-months mavacamten treatment in obstructive hypertrophic cardiomyopathy

12 December 2025 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: What is new in hypertrophic cardiomyopathy Myocardial Disease EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)